PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) › Total AssetsPROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $14.40M2011: $13.35M2012: $6.20M2013: $20.01M2014: $26.18M2015: $20.44M2016: $5.61M2017: $3.44M2018: $1.99M2019: $1.48M2020: $589.2K2021: $3.51M2022: $2.04M2023: $1.45M2024: $1.01M2025: $697.5K$697.5K2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$697.5K-30.7%2024$1.01M-30.5%2023$1.45M-28.9%2022$2.04M-42.0%2021$3.51M+496.3%2020$589.2K-60.1%2019$1.48M-25.7%2018$1.99M-42.1%2017$3.44M-38.8%2016$5.61M-72.5%2015$20.44M-21.9%2014$26.18M+30.9%2013$20.01M+222.5%2012$6.20M-53.5%2011$13.35M-7.3%2010$14.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share